Byrne Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Byrne Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-17	Closed	–	–	570
2021 Q4	$0	Buy	+17	New	–	﹤0.01%	529

Byrne Asset Management's ANAC Position: Q1 2022 in Review

Byrne Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2022, closing a stake of 17 shares.

Byrne Asset Management first reported a position in ANAC in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 0 funds tracked by Wall St. Rank hold ANAC as of Q1 2022.

Byrne Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2022 after selling out during the quarter.
Byrne Asset Management sold 17 ANACOR PHARMACEUTICALS INC COM shares in Q1 2022.
Byrne Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2021 and held it in 1 quarter.
Byrne Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $0 in Q4 2021.
0 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2022.

Based on Byrne Asset Management's 13F filing for Q1 2022, filed 5 Apr 2022.